Published in JAMA Network Open · View the paper (DOI)
A recent study found that ivermectin-benzimidazole prescribing increased rapidly following a celebrity endorsement in January 2025. This trend was particularly concerning among patients with cancer who may delay conventional treatments for unproven therapies, potentially worsening their disease progression.
Coverage from 2 institutions